49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

about

Resistance to integrase inhibitors.

P2860

Q34059896-A243494F-5207-4E11-A9AC-9C4FE39F576E

P2860

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

Item

http://www.wikidata.org/entity/Q46172217

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@en

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@nl

type

Item

label

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@en

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@nl

prefLabel

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@en

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@nl

P1476

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

@en

P2093

Hannah R Palmer

http://www.w3.org/2001/XMLSchema#string

Rosa F Yeh

http://www.w3.org/2001/XMLSchema#string

Rupali Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Raltegravir with optimized background therapy for resistant HIV-1 infection

Aspergillosis case-fatality rate: systematic review of the literature.

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Maraviroc for previously treated patients with R5 HIV-1 infection

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.

Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.

P304

1167-1172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.09.106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19968509

http://www.w3.org/2001/XMLSchema#string

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

about

P2860

P2860

49th ICAAC annual meeting: optimization of anti-infective use in the clinical setting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698